Idorsia
Andrew Jones has over 20 years of work experience, with their most recent role being the VP, Head of Corporate Communications at Idorsia Pharmaceuticals Ltd since 2017. Prior to that, they held various positions at Actelion, including Head of Corporate Communications and Deputy Head of Corporate Communications. Andrew also has experience in content development, investor relations, and scientific communications.
Andrew Jones received a Bsc (Hons) degree in Biochemistry from Cardiff University / Prifysgol Caerdydd, where they studied from 1993 to 1996.
This person is not in any teams
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.